Sexual attitude and perception on sexual relationship among long-term users of sildenafil.
BACKGROUND
High discontinuation rates of sildenafil were reported in its responders.


OBJECTIVE
To investigate perception on and attitude toward sex among long-term users of sildenafil.


METHODS
A survey was conducted using random face-to-face interviews and a structured questionnaire on a population of 105 long-term sildenafil users (mean age; 57.8 years), who first took sildenafil 5 years or more previously and continued its use in the previous 6 months.


METHODS
Six point-scale of perception on and attitude toward sex and valuation of sildenafil.


RESULTS
Among the long-term users, 98% perceived that it is desirable to have sex even though they get old if they are healthy, 93% had a positive attitude toward sex, and 97% had an intercourse-focused perception of sexual relationship; these rates were higher for those with a lower income and less education. And 59% had intercourses and 40% took sildenafil one to two times a week. They ranked prominence in rigidity of erection as the major reason for the long-term sildenafil use. The rigidity was maintained after more than 5-year use.


CONCLUSIONS
An overall majority of the long-term users of sildenafil had a positive attitude toward sex, an active sexual behavior, and an intercourse-focused perception on sexual relationship. Sildenafil provided an optimal fit for the patients' needs. Prominence in rigidity of erection was ranked as the major reason for the long-term use.
Kim
Sae-Chul
SC
Department of Urology, Chung-Ang University College of Medicine, Seoul, Korea. saeckim@unitel.co.kr
D000368:Aged; D001294:Attitude to Health; D003075:Coitus / Q000523:psychology; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008393:Marriage / Q000523:psychology*; D008875:Middle Aged; D017060:Patient Satisfaction; D010410:Penile Erection / Q000187:drug effects; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D011687:Purines / Q000009:adverse effects / Q000627:therapeutic use; D012725:Sexual Behavior / Q000187:drug effects*; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000009:adverse effects / Q000627:therapeutic use*; D011795:Surveys and Questionnaires
D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate